B-cell maturation antigen (BCMA)-directed bispecific antibodies have tolerable safety profiles in frail patients with relapsed/refractory multiple myeloma (MM), according to a real-world study ...

“The largest absolute increases in early-onset cancers were observed for female breast, colorectal, kidney, and uterine cancers,” the researchers wrote. The incidence of early-onset cancers in ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

Pharmaceutical tariffs could increase drug prices and drug shortages, negatively impacting the health care system, experts warn.

We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.

The guidelines now state that vorasidenib may be an option for certain patients.

Source: Getty Images Washington state’s attorney general alleges the Trump administration has violated a preliminary injunction intended to stop it from cutting research funding. This article ...

Adding penpulimab to chemotherapy can improve progression-free survival for patients with recurrent or metastatic nasopharyngeal carcinoma, data suggest.

The FDA has granted accelerated approval to Avmapki (avutometinib) plus Fakzynja (defactinib) for the treatment of KRAS-mutated, recurrent low-grade serous ovarian cancer.